George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 64,300 shares at $1.99 ($128K) on 2020-05-12, disclosed to the SEC on 2020-05-13.
Open-market sale of $128k CLSD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.99 | 32,150 | $64K | 50.0% |
| 2 | $1.99 | 32,150 | $64K | 50.0% |
| Total | $1.99 avg | 64,300 | $128K | 100% |
| Filing → |
| CLSD | SELL | 2022-01-20 | $23K | — | Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |